Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas

1 May 1999

Abstract excerpt

Many studies have tried to discriminate malignant from benign phaeochromocytomas, but until now no widely accepted histological, immunohistochemical, or molecular methods have been available. In this study of 29 malignant and 85 benign phaeochromocytomas from 102 patients, immunohistochemistry was performed with antibodies to the tumour suppressor gene product p53 and the proto-oncogene products bcl-2 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer-related Molecular Pathways
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10398140
DOI: 10.1002/(sici)1096-9896(199905)188:1<51::aid-path310>3.0.co;2-r

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomasPMID 10398140Read ↗

ERBB-2 overexpression as a risk factor for malignant phaeochromocytomas and paraganglinomas.Semantic proximity Read ↗

Establishment and evaluation of a novel biomarker-based nomogram for malignant phaeochromocytomas and paragangliomas.Semantic proximity Read ↗

p53 over‐expression identifies a subset of nodal peripheral T‐cell lymphomas with a distinctive biological profile and poor clinical outcomeSemantic proximity Read ↗

Expression of bcl-2 and p53 in Merkel Cell CarcinomaSemantic proximity Read ↗

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.Semantic proximity Read ↗

Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations.Semantic proximity Read ↗

Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: Can they predict treatment response and clinical outcome?Semantic proximity Read ↗

Human gliomas with wild-type p53 express bcl-2.Semantic proximity Read ↗

A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients.Semantic proximity Read ↗

Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.Semantic proximity Read ↗

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma.Semantic proximity Read ↗

bcl-2 Expression in PilomatricomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.